Oreola Donini
Directeur Technique/Scientifique/R&D chez SOLIGENIX, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Oreola Donini
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLIGENIX, INC. | Directeur Technique/Scientifique/R&D | 15/08/2013 | - |
Historique de carrière de Oreola Donini
Anciens postes connus de Oreola Donini
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2007 | 01/01/2013 |
| ESSA PHARMA INC. | Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/01/2013 |
| Kinetek Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
Formation de Oreola Donini
| Queen's University | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Statistiques
Internationale
| Canada | 5 |
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
| Kinetek Pharmaceuticals, Inc. | Health Technology |
- Bourse
- Insiders
- Oreola Donini
- Expérience
